Blade Air Mobility, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Strata Critical Medical, Inc. announced its second quarter 2026 financial results, showcasing a substantial 60.7% increase in revenue to $72.5 million, primarily driven by strategic acquisitions in its Clinical segment.
Strata Critical Medical, Inc. announced a significant increase in revenue and a return to profitability in its first quarter of 2026, driven by strong performance in both its Logistics and Clinical segments.
Strata Critical Medical reported a significant net income increase in Q3 2025, driven by the divestiture of its Passenger business and strong growth in its core Medical segment, bolstered by the Keystone acquisition.
Blade Air Mobility reported a significant reduction in net loss and a swing to positive Adjusted EBITDA in Q2 2025, alongside the strategic sale of its Passenger business to Joby Aviation for up to $125 million.
Blade Air Mobility saw a revenue increase and a reduction in net losses for the first quarter of 2025, according to its latest 10-Q filing.
Blade Air Mobility's Q3 2024 results show a 5% increase in revenue compared to the same period last year, driven by growth in both passenger and medical transport segments.
Blade Air Mobility's Q2 2024 results show an 11% increase in revenue compared to the same period last year, driven by growth in both passenger and medical transport segments.
Blade Air Mobility saw a revenue increase in the first quarter of 2024, driven by growth in its medical transport segment, while also reducing its net loss compared to the same period last year.